Wilson & Boucher Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$504K Buy
548
+6
+1% +$6.08K 0.33% 72
2025
Q4
$583K Sell
542
-50
-8% -$47.8K 0.38% 64
2025
Q3
$452K Hold
592
0.3% 78
2025
Q2
$462K Sell
592
-7
-1% -$5.44K 0.32% 78
2025
Q1
$495K Sell
599
-40
-6% -$33.3K 0.37% 74
2024
Q4
$493K Sell
639
-101
-14% -$83.6K 0.35% 75
2024
Q3
$656K Buy
740
+101
+16% +$90.8K 0.45% 59
2024
Q2
$578K Buy
639
+262
+69% +$210K 0.44% 61
2024
Q1
$294K Buy
+377
New +$268K 0.23% 91

Other funds holding LLY

Wilson & Boucher Capital Management's LLY Position: Q1 2026 in Review

Wilson & Boucher Capital Management increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $6.08K and bringing the position to 548 shares worth $504K. The position accounts for 0.33% of the portfolio, ranked #72.

Wilson & Boucher Capital Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $656K in Q3 2024. 4,358 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wilson & Boucher Capital Management held 548 shares of Eli Lilly worth $504K as of Q1 2026.
  • Wilson & Boucher Capital Management bought 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
  • Eli Lilly made up 0.33% of Wilson & Boucher Capital Management's portfolio in Q1 2026, its #72 holding.
  • Wilson & Boucher Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Wilson & Boucher Capital Management's Eli Lilly position peaked at $656K in Q3 2024.
  • 4,358 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wilson & Boucher Capital Management's 13F filing for Q1 2026, filed 18 May 2026.